06/02/2025
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
06/02/2025
4:04 PM | Benitec Biopharma (Filer)
| Form 424B3 | |
05/23/2025
3:32 PM | Benitec Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/15/2025
3:38 PM | Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
11:49 AM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025
7:00 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
6:09 AM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2025
12:06 PM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
04/02/2025
3:37 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
3:50 PM | Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/28/2025
3:51 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BNTC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. |
03/27/2025
4:10 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
9:53 AM | Benitec Biopharma (Filer)
| Form 424B5 | |
03/26/2025
7:13 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
4:25 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
6:18 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
3:43 PM | Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
1:20 PM | Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
11:37 AM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
7:19 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
6:51 AM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
02/13/2025
3:15 PM | Benitec Biopharma (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025
11:51 AM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
01/03/2025
4:39 PM | Benitec Biopharma (Issuer)
Mukadam Sophie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/31/2024
5:34 AM | Benitec Biopharma (Filer)
| Form 8-K/A | |
12/26/2024
3:28 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
3:15 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
5:48 PM | Benitec Biopharma (Issuer)
Mehta Kishan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:17 PM | Benitec Biopharma (Issuer)
Boston Megan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:19 PM | Banks Jerel A. (Reporting)
Benitec Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:20 PM | Benitec Biopharma (Issuer)
Smith Edward F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:22 PM | Benitec Biopharma (Issuer)
BUCHI J KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2024
4:24 PM | Benitec Biopharma (Issuer)
Francis Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
4:01 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
12:47 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
12/05/2024
3:36 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:36 PM | Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A | |
11/14/2024
3:53 PM | Benitec Biopharma (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/14/2024
3:32 PM | Benitec Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
11:15 PM | Benitec Biopharma (Filer)
| Form EFFECT | |
11/07/2024
11:30 AM | Benitec Biopharma (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
11/06/2024
2:26 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/01/2024
4:04 PM | Benitec Biopharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/25/2024
1:19 PM | Benitec Biopharma (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
10/23/2024
8:23 AM | Benitec Biopharma (Filer)
| Form DEF 14A | |
10/22/2024
4:24 PM | Benitec Biopharma (Filer)
| Form DEFA14A | |
10/15/2024
7:07 AM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
5:08 AM | Benitec Biopharma (Filer)
| Form 424B5 | |
10/11/2024
4:13 PM | Benitec Biopharma (Filer)
| Form 424B5 | |
10/11/2024
3:52 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:53 PM | Benitec Biopharma (Filer)
| Form PRE 14A | |
10/08/2024
3:45 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:46 PM | Benitec Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/30/2024
4:17 PM | Averill Madison Master Fund, Ltd. (Reporting)
Averill Master Fund, Ltd. (Reporting)
Benitec Biopharma (Issuer)
Cowen Aaron (Reporting)
SUVRETTA CAPITAL MANAGEMENT, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:18 PM | Benitec Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13D/A | |
09/26/2024
3:30 PM | Benitec Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/26/2024
3:43 PM | Benitec Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free BNTC Stock Alerts